¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"angle methyl group"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • group-specific antigen
    ¹«¸®Æ¯ÀÌÇ׿ø, ±ºÆ¯ÀÌÇ׿ø
  • high risk group
    °íÀ§Ç豺
  • haptenic group
    ºÒ¿ÏÀüÇ׿ø±º, ÇÕÅÙ±º
  • linkage group
    ¿¬°ü±º
  • low risk group
    ÀúÀ§Ç豺
  • osmophore group
    ¹ßÇâ´Ü(Û¡úÅÓ¥)
  • prosthetic group
    1. º¸°áºÐÀÚ´Ü 2. º¸°á¿øÀÚ´Ü
  • Rh blood group system
    RhÇ÷¾×Çüü°è
  • soluble group
    °¡¿ëÇØ±º
  • self-help group
    ÀÚ°¡µµ¿òÁý´Ü
  • angle
    1. °¢ 2. ±¸¼®
  • angle ostectomy
    °¢ÁøÅλÀÀýÁ¦(¼ú), °¢ÁøÅÎÀý°ñ(¼ú)
  • angle recess
    ¾Õ¹æ°¢°ñ, Àü¹æ°¢Àú, °¢¿À¸ñ
  • angle recession
    ¾Õ¹æ°¢µÚ¹°¸², Àü¹æ°¢ÈÄÅð
  • angle recession glaucoma
    ¾Õ¹æ°¢ÈÄÅð³ì³»Àå, Àü¹æ°¢ÈÄÅð³ì³»Àå
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • group-specific
    ±ºÆ¯ÀÌ-
  • glucophore group
    ´ã´ç±â
  • green or yellow vegetable group
    ³ìȲ»öä¼Ò·ù
  • group hospital
    º´¿øÁ¶ÇÕ
  • group medicine
    Áý´ÜÁø·á, Çùµ¿Áø·á
  • group practice
    Áý´Ü°³¾÷
  • group psychotherapy
    Áý´ÜÁ¤½Å¿ä¹ý
  • group displacement law
    Áý´Üº¯À§¹ýÄ¢
  • group fascicular repair
    ½Å°æ¼¶À¯´Ù¹ß±ººÀÇÕ(¹ý)
  • group reference value
    Áý´Ü±âÁØÄ¡
  • haptenic group
    ºÒ¿ÏÀüÇ׿ø±º, ÇÕÅÙ±º
  • high risk group
    °íÀ§Çèµµ±º
  • index group
    ÃʹßȯÀÚ±º
  • linkage group
    ¿¬°ü±º
  • marathon group
    ¸¶¶óÅæÁý´Ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gastric angle
    À§°¢(êÖÊÇ).
  • gingival point angle
    Ä¡°æÃ·°¢(öÍ ôÓÊÇ).
  • great angle of eye
    ³»¾È°¢(Ò®äÑÊÇ).
  • hinge angle
    °æÃ¸°¢
  • imminent angle-closure glaucoma
    Àý¹ÚÆó¼â°¢³ì³»Àå
  • incisal angle
    Àý´Ü°Ý°¢(ôîӮ̰ÊÇ).
  • incisal guidance angle
    ÀýÄ¡À¯µµ°æ»ç°¢.
  • incisal point angle
    Àý´Ü¿¬Ã·°¢(ôîÓ®æÞôÓÊÇ).
  • inferior angle
    ¾Æ·¡°¢, Çϰ¢(ù»ÊÇ).
  • inferior angle
    ¾Æ·¡°¢
  • phase angle
    À§»ó°¢(êÈßÓÊÇ).
  • phase angle
    À§»ó °¢
  • point angle
    Á¡°¢(ïÇÊÇ), ÷°¢(ôÓÊÇ).
  • polarization angle
    Æí±¤°¢(ø¶ÎÃÊÇ).
  • posterior urethrovesical angle
    Èĺο䵵¹æ±¤°¢
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • blood group specific substance
    Ç÷¾×ÇüƯÀ̹°Áú.
  • blood group system
    Ç÷¾×Çü±º
  • borderline group
    °æ°è±º(ÌÑÍ£ÏØ).
  • carbohydrate, group-specfic C
    ±ºÆ¯ÀÌ C ź¼öÈ­¹°
  • coliform group
    ´ëÀå±Õ±º
  • commutative group
    °¡È¯±º(˧̷˴).
  • commutator group
    ±³È¯ÀÚ±º(ÊÙË´).
  • complementation group
    »óº¸¼º Áý´Ü
  • complementophil group
    º¸Ã¼Ä£È­±â.
  • control group
    ´ëÁ¶±º(ÓßðÎÏÛ)
  • control group
    ´ëÁ¶±º(ËÀ̡˴).
  • determinant group
    °áÁ¤±º(¡­ÏØ).
  • diagnosis related group(DRG)
    Áø´Ü¸íº° ±º, À¯»çÇÑ Áø´Ü¸íµé³¢¸® ¹­¾î À̸¦ ´ÜÀ§·Î ÀÇ·áºñ¸¦ ÁöºÒÇÏ´Â ¹æ¹ý
  • diagnostic related group
    Áø´Ü°ü·Ã±º
  • didactic group therapy
    ±³À°Àû Áý´Ü¿ä¹ý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • azo group
    ¾ÆÁ¶±â(Ðñ)
  • bathochromic group
    ÀåÆÄ»ö´Ü±º(íþ÷îßäÓ¥ÏØ)
  • blocking group
    Â÷´Ü±â(ó´Ó¨Ðñ)
  • carbamoyl group
    Ä«¸£¹Ù¸ðÀÏ ±â(Ðñ)
  • carbonyl group
    Ä«¸£º¸´Ò±â(Ðñ)
  • carboxyl group
    Ä«¸£º¹½Ç±â(Ðñ)
  • complementation group
    »óº¸±º(ßÓÜÍÏØ)
  • critical group
    ÀӰ豺(×üÍ£ÏØ)
  • diazo group
    µð¾ÆÁ¶ ±â(Ðñ)
  • diazonium group
    µð¾ÆÁ¶´½ ±â(Ðñ)
  • earthy group
    Å伺±â(÷ÏàõÐñ)
  • end-group analysis
    Á¾´Ü±â ºÐ¼® (ðûÓ®ÐñÝÂà°)
  • fatty acyl group
    Áö¹æ(ò·Û¸) ¾Æ½Ç±â(Ðñ)
  • fidelity group
    Á¤È®µµ ±â(ïáü¬ÓøÐñ)
  • formimino group
    Æ÷¸§À̹̳ë±â(Ðñ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • sternal angle
    Èä°ñ°¢
  • vertical angle
    ¼öÁ÷°¢
  • wide angle lens
    ±¤°¢·»Áî
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
DRG diagnosis-related group; Division of Research Grants [NIH}; dorsal respiratory group; dorsal root ga...
GS gallstone; Gardner syndrome; gastric shield; general surgery; gestational score; Gilbert syndrome; g...
GT gait training; galactosyl transferase; gastrostomy; generation time; genetic therapy; gingiva treatm...
MN a blood group in the MNSs blood group system; malignant nephrosclerosis; Master of Nursing; meganewt...
CPA tumor Cerebello-Pontine Angle(¼Ò³ú±³°¢ºÎ) tumor
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
group II group I
Group III group
5-methyl-[1,2,4]oxadiazol-3-yl 2'-Methyl-4
1-Methyl-2-Pyrrolidinyl S)-3-Methyl-5
CPA Cerebellopontine Angle
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute and late normal tissue effects£¨Á¤»ó Á¶Á÷ ±Þ¼º ¿µÇ⣩

    acute angle

    ¿¹°¢
    Á÷°¢º¸´Ù ÀÛÀº °¢.
  • alveolar angle
    Ä¡Á¶ °¢
  • ANB angle
    ANB°¢
    µÎ°³°èÃøÇÐÀûÀ¸·Î, AÁ¡°ú ºñ±ÙÁ¡. ±×¸®°í BÁ¡À» ÀÕ´Â ¼±ÀÇ °¢µµ.
  • angle band
    ¾Þ±Û ´ëȯ
  • angle fracture
    ¿ì°¢ºÎ °ñÀý
    Á¦ 2´ë±¸Ä¡ÀÇ ÈĹ濡¼­ ÇϾÇÁö¿Í ÇϾÇü¸¦ ¿¬°áÇÏ´Â ºÎºÐ±îÁö ¿¬°áµÈ °ñÀý.
  • angle of cervical convergence
    Ä¡°æºÎ ¼ö·Å°¢
    Áö´ëÄ¡¿¡ Á¢ÃËÇÏ´Â ¼öÁ÷ºÀ°¡ Áö´ëÄ¡ÀÇ ÀåÃà¸é »çÀÌ¿¡¼­ Çü¼ºµÇ´Â °¢ÀÌ´Ù. À̰ÍÀº ±× ÷Á¡ÀÌ Áö´ëÄ¡ÀÇ ÃÖ´ë dzÀ¶ºÎ¿¡ ÀÖ´Â Ä¡±Ù´Ü °¢À¸·Î¼­, Ŭ·¡½ºÇÁ¸¦ ÅëÇØ ±ÕÀÏÇÑ À¯Áö¸¦ ¾òÀ¸·ÁÇÒ ¶§ Áß¿äÇÏ´Ù.
  • angle of declination
    ¹æÀ§ °¢
  • angle of deviation
    ÆíÀ§ °¢, »ç½Ã °¢
  • angle of friction
    ¸¶Âû °¢
  • angle of incidence
    ÀԻ簢
    ±¤¼±ÀÇ Ãà°ú ´ë»ó¹°ÀÇ Ç¥¸é¿¡ ´ëÇØ ¼ö¼±ÀÌ ÀÌ·ç´Â °¢.
  • angle of mouth
    ±¸°¢
  • angle of reflection
    ¹Ý»ç °¢
    ¹Ý»çµÈ ±¤¼±ÀÇ Ãà°ú ´ë»ó¹°ÀÇ Ç¥¸é¿¡ ´ëÇØ ¼ö¼±ÀÌ ÀÌ·ç´Â °¢.
  • angle of strabismus
    »ç½Ã °¢
  • angle of undercut
    °¢Çü ÷¿Í
  • Angle's classification of malocclusion
    ºÎÁ¤±³ÇÕÀÇ Angle ºÐ·ù
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
methyl n-butyl ketone <chemical> 2-hexanone. An industrial solvent which causes nervous system degeneration. Synonym: mbk.
Chemical name: 2-Hexanone
(12 Dec 1998)
methyl nicotinate Nicotinic acid methyl ester, used as rubefacient.
(05 Mar 2000)
methyl orange C14H14N3O3SNa;a weakly acid dye used as a pH indicator (red at 3.2, yellow at 4.4).
Synonym: helianthine.
(05 Mar 2000)
methyl parathion <chemical> Phosphorothioic acid, o,o-dimethyl o-(4-nitrophenyl) ester. The methyl homolog of parathion. An effective, but highly toxic, organothiophosphate insecticide and cholinesterase inhibitor.
Pharmacological action: cholinesterase inhibitor, insecticide, organothiophosphate.
Chemical name: Phosphorothioic acid, O,O-dimethyl O-(4-nitrophenyl) ester
(12 Dec 1998)
methyl-p-hydroxyphenyllactate esterase <enzyme> May be involved in regulation of cell growth in normal and neoplastic tissues
Registry number: EC 3.1.1.-
Synonym: mehpla-ase
(26 Jun 1999)
methyl red C15H15N3O2;a weakly acid dye used as a pH indicator (red at 4.8, yellow at 6.0); easily reduced with loss of colour, and pH readings must be made rapidly.
(05 Mar 2000)
methyl salicylate Aromatic methyl ester of salicylic acid, produced synthetically or distilled from Gaultheria procumbens (family Ericaceae) or from Betula lenta (family Betulaceae).
Used as a component of liniments, used externally and internally for the treatment of various forms of rheumatismit produces heat when rubbed into the skin (counterirritant).
Synonym: checkerberry oil, gaultheria oil, sweet birch oil, wintergreen oil.
(05 Mar 2000)
methyl sterol oxidase <enzyme> Converts sterol 4-methyl to carboxylic acid; requires NADH or NADPH
Registry number: EC 1.-
Synonym: methyl sterol mixed function oxidase, 4-methyl sterol oxidase, methylsterol oxidase, 4alpha-methylsterol oxidase
(26 Jun 1999)
methyl sulfoxide reductase <enzyme> Reduces methyl sulfoxide group to methyl sulfide on various xenobiotics
Registry number: EC 1.8.99.-
Synonym: methyl sulfoxide reductase I, methyl sulfoxide reductase II
(26 Jun 1999)
methyl-tert-butyl ether Used to dissolve gallbladder stones.
Acronym: MTBE
(05 Mar 2000)
methyl violet Mixtures of tetra-, penta-, or pararosanilin which vary in shade of violet depending on the extent of methylation (designated R for reddish shades, B for bluish shades); the hexamethyl compound is known as crystal violet, the pentamenthyl compound as methyl violet 6B. As stains, methyl violet has many bacteriological, histological, and cytological applications.
(05 Mar 2000)
methyl xanthine <chemical, drug> Naturally occurring purine alkaloids such as theobromine, theophylline and caffeine (trimethyl xanthine). They inhibit cAMP phosphodiesterase and thus cause an increase in the intracellular cAMP concentration.
(18 Nov 1997)
methyl yellow C6H5N:NC6H4N(CH3)2;a fat-soluble yellow dye (MW 225) that has hepatic carcinogenic action in experimental animals; used as an indicator of pH (red, at pH 2.9, yellow at pH 4.0).
Synonym: dimethylaminoazobenzene, methyl yellow.
(05 Mar 2000)
p,p'-dichlorodiphenyl methyl carbinol A synthetic compound found effective as a miticide.
Acronym: DMC
(05 Mar 2000)
S-adenosyl-L-methionine-2-octaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone-O-methyltransferase <enzyme> Proposed pathway for final reaction in ubiquinone biosynthesis.
Registry number: EC 2.1.1.-
Synonym: 2-octaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone methyltransferase, ubig gene product, ubig protein
(26 Jun 1999)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • round angle
    ÁÖ°¢;4Á÷°¢
  • age-group
    ¿¬·É Áý´Ü
  • group
    Áý´Ü,¶¼¸¦ Áþ´Ù,ºÐ·ùÇÏ´Ù
  • Group of 77
    77°³±¹ ±×·ì(UNÀÇ ¹«¿ª°³¹ß ȸÀÇ(UNCTAD)ÀÇ È¸¿øÀÎ ¹ßÀü µµ»ó±¹ ±×·ì)
  • Group of Seven
    G;7 ¼±Áø 7°³±¹ ±×·ì
  • blood group
    Ç÷¾×Çü Á¤
  • code group
    ºÎÈ£±º
  • continuous group
    ¿¬¼Ó±º
  • control group
    Á¦¾îÁý´Ü;Á¶Á¾ÀåÄ¡;´ëÁ¶±º(µ¿ÀϽÇÇè¿¡¼­ ½ÇÇè¿ä°ÇÀ» °¡ÇÏÁö ¾ÊÀº ±×·ì)
  • enxounter group
    (Á¤ÀÇ)Áý´Ü °¨¼ö¼º ÈÆ·Ã ±×·ì
  • ethnic group
    (»çȸ)ÀÎÁ¾ Áý´Ü
  • focus group
    Æ÷Ä¿½º ±×·ì(Å×½ºÆ®ÇÒ »óǰ¿¡ ´ëÇØ¼­ ÅäÀÇÇÏ´Â ¼ÒºñÀÚ ±×·ì)
  • fringe group
    ºñÁÖ·ùÆÄ
  • front group
    (À§ÀåÇÑ) Ç¥¸é»óÀÇ Á¶Á÷(´Üü)
  • ginger group
    (Á¤´ç µûÀ§ Á¶Á÷ ³»ºÎÀÇ)Çõ½ÅÆÄ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á